Maxxim Medical Management-Led Leveraged Buyout Valued At $800 Mil.
This article was originally published in The Gray Sheet
Executive Summary
The management of Maxxim Medical plans to take the specialty medical products company private with the help of Foster City, California-based investment firm Fox Paine & Company and Chase Manhattan.
You may also be interested in...
Maxxim Sale To Lightyear Resolves Bankruptcy; Management Likely To Stay
Investment firm Lightyear Capital's acquisition of Maxxim Medical will strengthen the procedure tray manufacturer's balance sheet and enable it to emerge from bankruptcy proceedings largely intact, the company asserts
Maxxim Sale To Lightyear Resolves Bankruptcy; Management Likely To Stay
Investment firm Lightyear Capital's acquisition of Maxxim Medical will strengthen the procedure tray manufacturer's balance sheet and enable it to emerge from bankruptcy proceedings largely intact, the company asserts
Maxxim Medical
Extends to Nov. 10 the expiration of its offer to purchase for cash any and all of the $100 mil. aggregate principal amount of its outstanding 10-1/2% senior subordinated notes due 2006. Holders of over $99.9 mil. of the notes had tendered their notes and delivered consents to amendments prior to the consent expiration date. Previously scheduled to expire on Oct. 29, the tender offer was launched in connection with Maxxim's previously announced proposal to merge with Fox Paine Medic Acquisition Corporation and recapitalize the company (1"The Gray Sheet" June 21, p. 19). The merger is expected to close in "mid-November," Maxxim says